# Y-6 Sublingual Tablets for Patients With Acute Ischemic Stroke

> **NCT07040085** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 892 (estimated)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Y-6
- **DRUG:** Y-6 placebo

## Key facts

- **NCT ID:** NCT07040085
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-05
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 892 (ESTIMATED)
- **Last updated:** 2025-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07040085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07040085, "Y-6 Sublingual Tablets for Patients With Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07040085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*